ArticleBreast cancer research and treatment2025

Duration and effect of neoadjuvant endocrine therapy on invasive tumor cellularity in hormone receptor-positive breast cancer.

Amanda Sutherland Beck et al.PubMed ↗Publisher ↗

No numbers read from the abstract.